While there is some sympathy for our mid-cycle transition, most think it’s too early, or not worth acting on. There is also push back on our call for lower valuations and some of our specific relative value trades. Finally, investors are more bullish on the earnings outlook for next year. Some,gradual, buy in to the mid-cycle transition. We laid out…
Morgan Stanley Weekly Warm-up: Feedback to our Mid Year Outlook
A financial market resource for the every-day investor and trader.
-
Sentiment, Leverage, Is it Early 2018 Again or…?
Seth Golden, , Research Reports, 0
Please click the following link to review our commentary on Sentiment, Leverage, Is it Early 2018 Again or…? What...
-
Weekly State of the Market: Downtrend Persists
Seth Golden, , Research Reports, 0
I bought Alibaba when everyone was selling it. I knew about the headlines, the China-tech crackdowns, and the inherent...
-
Merrill Lynch Capital Market Outlook: December 2019
Seth Golden, , Research Reports, 0
IN THIS ISSUE Macro Strategy—A fundamental change in the Federal Reserve’s (Fed’s) approach to achieving its inflation target means...
-
Morgan Stanley’s Weekly Warm-up: Inflation Data and Fed Is Yesterday’s News; Focus on Earnings Risk
Seth Golden, , Research Reports, 0
This week’s focus is likely to be centered on CPI and the Fed. To us, that is yesterday’s news;...
-
SVB’s failure is not a Lehman moment
Seth Golden, , Research Reports, 0
By Ian Shephardson of Pantheon Macro Economic Slowing Wage Gains will Give the Fed Room to Pause, but not...
-
Weekly State of the Market: Taper Tantrum Afoot?
Seth Golden, , Research Reports, 0
They say the trading hierarchy is 10% Technical analysis, 30% Risk Management and 60% Patience & Emotion management. If...
-
The Bear Market Survival Is Now Inflation Dependent
Seth Golden, , Research Reports, 0
The S&P 500 (SPX) rallied sharply this past week, gaining 6.45 percent. This is the second 6%+ weekly gain...
-
J.P. Morgan: Market and Volatility Commentary
Seth Golden, , Research Reports, 0
Good day Finom Group members. As I continue to recover from my illness early this year (cough/cold), we will...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00